9th Annual meeting of the International Cytokine and Interferon Society Meeting

NIH支持科学会议- R13资助申请 摘要 本申请的目的是为细胞因子2021混合会议：第9届年会申请财政支持 2021年10月17日至20日在英国威尔士卡迪夫举行的国际细胞因子和干扰素学会（ICIS）会议， 同步虚拟会议平台，包括11月10日之前的实时流媒体和点播访问， 2021.这次年会有助于弥合从事分子生物学基础研究的科学家之间的差距。 以及免疫细胞激活和功能的细胞机制， 变成新的疗法。细胞因子和干扰素是免疫应答的有效效应物，也是免疫应答的主要调节因子。 调节许多不同的生理过程。这次会议的重点是汇集科学家从 生物医学研究的不同领域，讨论最新的突破和见解如何细胞因子和 干扰素调节免疫、炎症、代谢和癌症。更好地理解 疾病和治疗的新概念已经并将继续从多学科的聚会中出现， 可以由知名科学家和实习科学家介绍和讨论进展情况。 我们希望与会者将更深入地了解细胞因子如何网络在一起，以维持 健康和获得赞赏的许多潜在的战略，针对网络，以创造更好的药物。 会议将为基础科学和临床研究人员提供一个杰出的论坛， 他们最新的发现，细胞因子的作用（包括干扰素，趋化因子，和各种前， 炎症/抗炎因子）在感染、癌症、变态反应和自身免疫中，以及在各种其它 炎症和免疫性疾病。会议还将提供机会， 在这些领域开发新的治疗干预措施，并帮助促进国际合作， 会议的与会者。 在线演示将与物理演示和会议交织在一起，包括虚拟互动， 现场评论，在线和视频聊天论坛，网络直播视频演示和个人机会 讨论ICIS会议委员会和理事会已决定使用定制的虚拟会议 即使在旅行限制放宽后，平台也将使年会更具包容性， 会议更加可持续。 共同主席和地方组织委员会（由5名科学家组成，3名男性 和2名女性），通过汇集领导人，初级调查员和在该领域工作的受训人员， 干扰素和细胞因子的研究，这次会议将激发重要的新途径的调查，并将 对细胞因子生物学领域有前途的年轻研究者和受训者的职业发展大有裨益 领域

NIH Support for Scientific Conference – R13 Grant Application ABSTRACT The purpose of this application is to request financial support for the Cytokines 2021 Hybrid Meeting: 9th Annual Meeting of the International Cytokine & Interferon Society (ICIS), October 17-20, 2021 in Cardiff, Wales, UK with synchronous Virtual Meeting Platform including live streamed and on-demand access through November 10, 2021. This Annual Meeting helps bridge the gap between the scientists performing basic research on molecular and cellular mechanisms of immune cell activation and function with those working to develop this knowledge into novel therapies. Cytokines and interferons are potent effectors of an immune response and also are master regulators of many diverse physiologic processes. The focus of this meeting is to bring together scientists from diverse areas of biomedical research to discuss the latest breakthroughs and insights into how cytokines and interferons regulate immunity, inflammation, metabolism, and cancer. Greater understanding of mechanisms of disease and novel concepts for therapy have and will continue to emerge from multidisciplinary gatherings where advances can be presented and discussed by established and trainee scientists. It is our hope that attendees will gain a deeper understanding of how cytokines network together to maintain health and gain an appreciation for the many potential strategies for targeting the network to create better drugs. The meeting will provide an outstanding forum for investigators in basic science and clinical research to present their most recent findings on the role of cytokines (including interferons, chemokines, and various pro- inflammatory/anti-inflammatory factors) in infection, cancer, allergy and autoimmunity, as well as in various other inflammatory and immune diseases. The meeting will also provide an opportunity for updates on the development of novel therapeutic interventions in these fields and help spur international collaborations among the meeting participants. Online presentations will be intertwined with physical presentations and sessions including virtual interactions, live commentaries, online & video chat forums, webcast video presentations and opportunities for individual discussion. ICIS Meetings Committee and Council have decided that use of a customized Virtual Meeting Platform even after travel restrictions are relaxed, will make the Annual Meeting more inclusive and make the meetings more sustainable. It is the firm belief of the Co-Chairs and Local Organizing Committee (diversely composed of 5 scientists, 3 male and 2 female) that, by bringing together leaders, junior investigators, and trainees working in the area of Interferon and Cytokine research, this meeting will inspire important new avenues of investigation and will be of great benefit to the career development of promising young investigators and trainees in the cytokine biology field.